Background: The incremental shuttle walking test (SWT) has recently been proposed as a more valid and reproducible alternative to the conventional 6-min walking test (6MWT) in the evaluation of exercise tolerance in patients with chronic obstructive pulmonary disease (COPD). Objective: To compare the cardiorespiratory performance obtained during two sessions of SWT with that obtained during two sessions of 6MWT. Methods: We examined 18 patients (forced expiratory volume in 1 s: 48 ± 14%) recovering from an acute exacerbation of COPD that had required hospitalization. In the same afternoon, each patient performed two SWT and two 6MWT, with an interval of at least 30 min between each test; the sequence of the tests was randomized. Results: Mean walking distance was greater in the second SWT test than in the first SWT. The changes from baseline in systolic blood pressure, heart rate, respiratory rate, oxygen saturation and dyspnea Borg index at the end of the test were similar between the two 6MWT and the two SWT. There was a highly significant correlation between walking distances measured during SWT and during 6MWT (ρ: 0.85, p < 0.0005). Neither SWT nor 6MWT correlated with functional data of COPD. Conclusions: SWT, though being considered to be closer to a submaximal exercise test than 6MWT, does not induce a greater cardiorespiratory performance than 6MWT in patients recovering from acute exacerbation of COPD.

1.
Wijkstra PJ, TenVergert EM, Van der Mark TW, Postma DS, Van Altena R, Kraan J, Koeter GH: Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease. Thorax 1994;49:468–472.
2.
Gosselink R, Troosters T, Decramer M: Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996;153:976–980.
3.
Agusti AGN, Cotes J, Wagner PD: Responses to exercise in lung diseases. Eur Respir Mon 1998;6:32–50.
4.
American Thoracic Society Statement: Pulmonary rehabilitation – 1999. Am J Respir Crit Care Med 1999;159:1666–1682.
5.
O’Donnell DE, McGuire M, Samis L, Webb KA: General exercise training improves ventilatory and peripheral muscle strength and endurance in chronic airflow limitation. Am J Respir Crit Care Med 1998;157:1489–1497.
6.
Butland RJA, Pang J, Gross ER, Woodcock AA, Geddes DM: Two-, 6-, and 12-minute walking tests in respiratory disease. Br Med J 1982;284:1607–1608.
7.
Knox AJ, Morrison JF, Muers MF: Reproducibility of walking test results in chronic obstructive airways disease. Thorax 1988;43:388–392.
8.
Singh SJ, Morgan MDL, Scott S, Walters D, Hardman AE: Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992;47:1019–1024.
9.
Singh SJ, Morgan MDL, Hardman AE, Rowe C, Bardsley PA: Comparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitation. Eur Respir J 1994;7:2016–2020.
10.
Steele B: Timed walking tests of exercise capacity in chronic cardiopulmonary illness. J Cardiopulm Rehabil 1996;16:25–33.
11.
Dyer CAE, Singh SJ, Stokley RA, Sinclair AJ: The incremental shuttle walking test in elderly people with chronic airflow limitation. Thorax 2002;57:34–38.
12.
Bradley J, Howard J, Wallace E, Elborn S: Validity of a modified shuttle test in adult cystic fibrosis. Thorax 1999;54:437–439.
13.
Green DJ, Watts K, Rankin S, Wong P, O’Driscoll JG: A comparison of the shuttle and 6-minute walking tests with measured peak oxygen consumption in patients with heart failure. J Sci Med Sport 2001;4:292–300.
14.
Elias Hernandez E, Ortega Ruiz F, Fernandez Guerra J, Toral Marin J, Sanchez Riera H, Montemayor Rubio T: Comparison of a shuttle walking test with an exertion test with cycloergometer in patients with COPD (in Spanish). Arch Bronconeumol 1997;33:498–502.
15.
Solway S, Brooks D, Lacasse Y, Thomas S: A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest 2001;119:256–270.
16.
Booth S, Adams L: The shuttle walking test: A reproducible method for evaluating the impact of breath on functional capacity in patients with advanced cancer. Thorax 2001;56:146–150.
17.
Bradley J, Howard J, Wallace E, Elborn S: Reliability, repeatability, and sensitivity of the modified shuttle test in adult cystic fibrosis. Chest 2000;117:1666–1671.
18.
Elpern EH, Stevens D, Kesten S: Variability in performance of timed walk tests in pulmonary rehabilitation programs. Chest 2000;118:98–105.
19.
Jones NL, Jones G, Edwards RHT: Exercise tolerance in chronic airway obstruction. Am Rev Respir Dis 1971;103:477–491.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.